SCHEMBL29769005

SCHEMBL29769005

CCC(Cl)(CC)c1ccccc1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.40
DPP4 P27487 1/20 0.36
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
ALDH1A1 P00352 3/20 0.35
HSD17B10 Q99714 2/20 0.35
HPGD P15428 1/20 0.35
BCL2L1 Q07817 1/20 0.35
MAPK1 P28482 1/20 0.35
ADRB2 P07550 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KCNQ2 O43526 1/20 0.34
MAPT P10636 1/20 0.34
HTR7 P34969 2/20 0.33
PTGS2 P35354 1/20 0.33
HSD11B1 P28845 1/20 0.33
BACE1 P56817 1/20 0.32
CNR2 P34972 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32
PTPN1 P18031 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8679018 0.79 DPP4 (0.39) CYP2A6DPP4PDCD1CD274ALDH1A1
SCHEMBL8679597 0.78 DPP4 (0.42) CYP2A6DPP4PDCD1CD274ALDH1A1
SCHEMBL127574 0.78 MAPK1 (0.41) CYP2A6DPP4PDCD1CD274ALDH1A1
SCHEMBL11108795 0.76 CYP2A6 (0.54) CYP2A6DPP4ALDH1A1HSD17B10HPGD
SCHEMBL16387926 0.74 PDCD1 (0.39) CYP2A6DPP4PDCD1CD274ALDH1A1
SCHEMBL9241713 0.74 ESR1 (0.36) CYP2A6DPP4PDCD1CD274ALDH1A1
SCHEMBL8679607 0.73 DPP4 (0.38) CYP2A6DPP4PDCD1CD274ALDH1A1
SCHEMBL677798 0.72 MAPK1 (0.40) CYP2A6DPP4PDCD1CD274ALDH1A1
SCHEMBL8679296 0.72 DPP4 (0.37) CYP2A6DPP4PDCD1CD274ALDH1A1
SCHEMBL27593989 0.72 SMN1; SMN2 (0.35) CYP2A6DPP4PDCD1CD274ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11414665-B2 Nucleic acid, composition and conjugate comprising the same, and preparation method and use thereof Suzhou Ribo Life Science Co., Ltd. (CN) 2022-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11414665-B2 Nucleic acid, composition and conjugate comprising the same, and preparation method and use thereof NSUN2, RNGTT, ADAR CYP2A6 1589/4885DPP4 4560/4885PDCD1 3869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.